Outcomes-based contracting in the US pharmaceutical market

Outcomes-based contracting in the US pharmaceutical market

Slides in the pack:

1. An introduction to outcomes-based contracting
2. Payers are looking for outcomes-based contracting in various therapeutic areas
3. History of outcomes-based contracting in the US
4. Outcomes-based contracts recently announced in the US
5. In 2015, Amgen negotiated its first pay-for-performance deal with Harvard Pilgrim for Repatha
6. In 2017, Amgen negotiated another outcomes-based contract with Harvard Pilgrim for Enbrel
7. Types of pharmaceutical outcomes-based contracts
8. Pre-conditions for the implementation of outcomes-based contracts
9. Benefits and challenges associated with outcomes-based contracts